title: Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.
authors.forename: Albert N
authors.initials: AN
authors.lastname: Békássy
authors.forename: Anna
authors.initials: A
authors.lastname: Locasciulli
authors.forename: Judith C W
authors.initials: JC
authors.lastname: Marsh
authors.forename: Gerard
authors.initials: G
authors.lastname: Socié
authors.forename: Monika
authors.initials: M
authors.lastname: Fuehrer
authors.forename: Jakob
authors.initials: J
authors.lastname: Passweg
mesh_terms: D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000401:mortality; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015996:Survival Rate
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine